Citation Impact
Citing Papers
Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway
2008
Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection
2007 StandoutNobel
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Principals of neovascularization for tissue engineering
2002
B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer
2008
Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells’ Subpopulations in the Peripheral Blood of Patients with Non–Small Cell Lung Cancer
2016
Altered macrophage differentiation and immune dysfunction in tumor development
2007
Other Functions, Other Genes
1999
Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism
2000
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Multi-protein assemblies underlie the mesoscale organization of the plasma membrane
2014 StandoutNobel
Evasion of Host Immune Responses by Tumours and Viruses
2007 Nobel
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55
2004
Colony-stimulating factors in inflammation and autoimmunity
2008
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
2008
Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells
2008
Nonresolving Inflammation
2010 Standout
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
2015 Nature
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
2013
Nanomaterials for cancer immunotherapy
2017
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
2006
Mechanisms and functional significance of tumour-induced dendritic-cell defects
2004
Macrophage-Derived Metalloelastase Is Responsible for the Generation of Angiostatin in Lewis Lung Carcinoma
1997
Immunity, Inflammation, and Cancer
2010 Standout
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D 3
2004
Myeloid-derived Suppressor Cells in Cancer Patients
2012
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Emerging Biological Principles of Metastasis
2017 Standout
Immunosurveillance of pancreatic adenocarcinoma: Insights from genetically engineered mouse models of cancer
2008
IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma
1999
Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production
2011 StandoutNobel
Inflammation and cancer: back to Virchow?
2001 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells
2009
Periodontal diseases
2005 Standout
Defining the Ability of Cyclophosphamide Preconditioning to Enhance the Antigen-specific CD8+ T-cell Response to Peptide Vaccination: Creation of a Beneficial Host Microenvironment Involving Type I IFNs and Myeloid Cells
2006
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
The Effect of Tetrathiomolybdate on Cytokine Expression, Angiogenesis, and Tumor Growth in Squamous Cell Carcinoma of the Head and Neck
2005
Interleukin 6 and Interleukin 8 as Potential Biomarkers for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
2004
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
2014
Hampering Immune Suppressors
2013
Metastatic colonization by circulating tumour cells
2016 StandoutNature
History of myeloid-derived suppressor cells
2013
Regulation of immune responses by L-arginine metabolism
2005
Cancer-related inflammation
2008 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
1α, 25 Dihydroxyvitamin D (1,25(OH)2D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC)
2019
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Alternative activation of macrophages
2003 Standout
Comparison of Serum Interleukin-10 (IL-10) Levels Between Normal Volunteers and Patients with Advanced Melanoma
2001
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
2007 Standout
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
2005
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor Cells
2004
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine
2007
Combination Docetaxel plus Vitamin D3 as an Immune Therapy in Animals Bearing Squamous Cell Carcinomas
2005
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Dendritic Cells and Tumor Microenvironment: A Dangerous Liaison
2006
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
2001 StandoutNobel
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
2001
Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells.
2002
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
2002
1α,25‐Dihydroxyvitamin D3 to skew intratumoral levels of immune inhibitory CD34+ progenitor cells into dendritic cells
2009
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
2006
CD28 disruption exacerbates inflammation in Tgf-β1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-β1
2004 StandoutNobel
CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses
2011 StandoutNobel
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
2007
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
2003 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Staining of interleukin-10 predicts clinical outcome in patients with nasopharyngeal carcinoma
1999
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
2001
A Dialogue between the Immune System and Brain, Spoken in the Language of Serotonin
2012
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor Immunotherapy
2001 StandoutNobel
Tumor-induced immune dysfunction: the macrophage connection
1998
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.
1996 StandoutNobel
Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
2005
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
2006
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells
2003
Apoptotic Death of CD8+ T Lymphocytes After Immunization: Induction of a Suppressive Population of Mac-1+/Gr-1+ Cells
1998
Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
1999
Disruption of T Cell Homeostasis in Mice Expressing a T Cell–Specific Dominant Negative Transforming Growth Factor β II Receptor
2000
Works of Mark A. Wright being referenced
Stimulation of the metastatic properties of lewis‐lung‐carcinoma cells by autologous granulocyte‐macrophage colony‐stimulating factor
1992
Myelopoiesis‐associated suppressor‐cell activity in mice with lewis lung carcinoma tumors: Interferon‐γ plus tumor necrosis factor‐α synergistically reduce suppressor cell activity
1990
Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor
1999
Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells
1997
Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence
1995
Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells
1991
Failure of tumor-reactive lymph node cells to kill tumor in the presence of immune-suppressive CD34+ cells can be overcome with vitamin D3 treatment to diminish CD34+ cell levels
1998
Regulation of Murine T-Lymphocyte Function by Spleen Cell-Derived and Exogenous Serotonin
1992
Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer
1996
Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells
1997
Cultures derived from peripheral blood CD34+ progenitor cells of head and neck cancer patients and from cord blood are functionally different
1999
Vitamin D3 Treatment to Diminish the Levels of Immune Suppressive CD34+ Cells Increases the Effectiveness of Adoptive Immunotherapy
2000
Stimulation of immune suppressive CD34 + cells from normal bone marrow by Lewis lung carcinoma tumors
1998
Vitamin D3 treatment of tumor bearers can stimulate immune competence and reduce tumor growth when treatment coincides with a heightened presence of natural suppressor cells
1996
Skewed differentiation of bone marrow CD34+ cells of tumor bearers from dendritic toward monocytic cells, and the redirection of differentiation toward dendritic cells by 1α,25-dihydroxyvitamin D3
1999
Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon ? plus tumor necrosis factor ?
1994
Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor β
1992
Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
1995
Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patients
1999
Treating tumor-bearing mice with vitamin D 3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence
1995
1 alpha,25-dihydroxyvitamin D3 plus gamma-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells.
1993
Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
1992
Inhibition of tumor production of granulocyte-macrophage colony-stimulating factor by 1 alpha, 25-dihydroxyvitamin D3 reduces tumor motility and metastasis.
1993
Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
1995
Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas.
1997
Vitamin D3 and ceramide reduce the invasion of tumor cells through extracellular matrix components by elevating protein phosphatase-2A.
1996
Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin.
1993
Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors.
1990
Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.
1996
Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte‐macrophage colony‐stimulating factor and contained CD34 natural suppressor cells
1997